Photo of J. Luis Correa
D United States House · District 46 · California On the 2026 ballot

Rep. J. Luis Correa

Compare
Total votes
2,837
all sessions
Attendance
97%
79 missed
Lower than 80% of chamber peers
With party
96%
of cast votes
Lower than 80% of chamber peers
Bipartisan score
2%
crosses aisle rarely
Higher than 79% of chamber peers
Sponsored
1,182
bills & resolutions
Near the chamber average
Committees
6
assignments
1,182 bills and resolutions

Sponsored bills

Total
1,182
Primary
69
Co-sponsor
1,113
This page
1,182
matching current filters
Co-sponsor HR 2693
In committee · United States House · Co-sponsor
Pay Our Coast Guard Parity Act of 2023

Maddy summaryHR 2693, the Pay Our Coast Guard Parity Act of 2023, ensures Coast Guard members, civilian staff, and qualifying contractors receive pay and benefits during specific funding gaps. It requires Congress to appropriate funds for Coast Guard personnel pay, allowances, and key benefits (like death gratuities and housing allowances) if a Coast Guard-specific funding lapse occurs - when Coast Guard funding isn’t approved before a fiscal year starts but Department of Defense funding is. The bill mandates these payments continue until a full appropriation is enacted or for up to two weeks after the lapse begins, with costs charged to future appropriations. This addresses a gap in funding continuity for Coast Guard personnel during government shutdowns affecting only the Coast Guard.

In committee Apr 19, 2023 1 co-sponsor
Co-sponsor HR 1624
In committee · United States House · Co-sponsor
Puppy Protection Act of 2023

Maddy summaryThe Puppy Protection Act of 2023 sets new standards for businesses that sell dogs (dealers), directly affecting pet stores and breeders operating under the Animal Welfare Act. It requires specific housing with space allowances based on dog size (e.g., 12-30 square feet per dog), temperature control (45-85°F), clean food twice daily, and daily exercise or socialization with humans/dogs for at least 30 minutes. The bill also mandates annual veterinary exams including dental care, strict breeding limits (e.g., age restrictions, maximum 2 litters in 18 months), and efforts to place retired breeding dogs in homes instead of selling them to other breeders. Regulations must be finalized within 18 months of enactment.

In committee Apr 19, 2023 1 co-sponsor
Co-sponsor HR 2413
In committee · United States House · Co-sponsor
Dental Care for Veterans Act

Maddy summaryHR 2413, the Dental Care for Veterans Act, reclassifies dental care as standard medical services under the VA's existing benefits structure, eliminating prior restrictions that treated dental care separately. It modifies how dental appliances are procured and establishes a phased eligibility timeline: veterans already eligible for dental benefits gain immediate access, while others qualify over 1-4 years based on their current benefit status. The bill affects all veterans currently covered under VA dental programs, changing their access to care without creating new funding. Key provisions streamline dental service delivery under Title 38, aligning it with other medical benefits.

In committee Apr 14, 2023 1 co-sponsor
Co-sponsor HR 2431
In committee · United States House · Co-sponsor
Veterans Equal Access Act

Maddy summaryThe Veterans Equal Access Act (HR 2431) allows Department of Veterans Affairs (VA) health care providers to give recommendations and opinions to veterans about participating in state-legal marijuana programs. It directly affects veterans living in states, the District of Columbia, Puerto Rico, U.S. territories, or federally recognized tribes where marijuana is permitted under state law. The bill requires the VA Secretary to authorize VA physicians and staff to provide these recommendations, complete related forms, and override any conflicting federal restrictions that previously prohibited such advice. This change enables veterans to receive guidance from VA providers regarding state marijuana programs without fear of VA disciplinary action.

In committee Apr 14, 2023 1 co-sponsor
Co-sponsor HR 1822
In committee · United States House · Co-sponsor
PLUS for Veterans Act of 2023

Maddy summaryThe PLUS for Veterans Act of 2023 clarifies and updates rules for veterans' benefit claims under the Department of Veterans Affairs. It sets a $12,500 annual fee cap (adjusted for inflation) for agents or attorneys representing veterans, prohibits charging fees for medical exams, and prohibits unauthorized fees with penalties including fines or up to one year in prison. The bill directly affects veterans seeking benefits, their legal representatives, and the VA by standardizing fee agreements, requiring VA reports on agent/attorney suspensions, and ensuring veterans can access free services from VA-recognized organizations. Key provisions include banning fees for medical reports and requiring clear fee disclosures to veterans.

In committee Apr 14, 2023 1 co-sponsor
Co-sponsor HR 2584
In committee · United States House · Co-sponsor
SAVE Act

Maddy summaryHR 2584, the SAVE Act, creates a new federal criminal offense for assaulting or intimidating hospital employees while they're performing their duties, punishable by up to 10 years in prison, with enhanced penalties for using weapons, causing injury, or during public emergencies. The bill authorizes $25 million annually in federal grants to hospitals for violence prevention programs, including staff training, security technologies like panic buttons and video surveillance, and coordination with law enforcement. It defines "hospital" broadly to include various medical facilities such as long-term care hospitals, rehabilitation facilities, and critical access hospitals. The legislation directly affects hospital workers and medical facilities by establishing federal criminal penalties for violence against employees and providing funding to improve workplace safety. The law aims to address the rising problem of workplace violence against healthcare workers, which the bill states has increased since 2011.

In committee Apr 13, 2023 1 co-sponsor
Co-sponsor HR 2630
In committee · United States House · Co-sponsor
Safe Step Act

Maddy summaryHR 2630, the Safe Step Act, requires group health plans and health insurance issuers to establish a clear, transparent process for patients or their doctors to request exceptions to medication step therapy protocols. These protocols typically force patients to try cheaper drugs first before covering more expensive alternatives. The bill mandates that plans must approve exceptions when prior treatments failed, delay would cause serious harm, a treatment is unsafe, or a patient is stable on a previously approved drug, with strict 72-hour (or 24-hour in emergencies) decision timelines. It also requires plans to publish the exception process online and limit documentation requests to only necessary medical information. This law directly affects health insurers, employers offering health plans, and patients using step therapy for prescription drugs.

In committee Apr 13, 2023 1 co-sponsor
Co-sponsor HR 2389
In committee · United States House · Co-sponsor
Resident Physician Shortage Reduction Act of 2023

Resident Physician Shortage Reduction Act of 2023 This bill increases the number of residency positions eligible for graduate medical education payments under Medicare for qualifying hospitals, including hospitals in rural areas and health professional shortage areas. Current law provides for an increase of up to 200 positions per fiscal year beginning in FY2023, with a total increase of 1,000 positions; each hospital may receive up to 25 additional positions. Current law also provides for an additional increase of up to 200 positions for FY2026, with at least 100 of these positions for psychiatry or related specialties; each hospital may receive up to 10 additional positions. The bill provides for an additional increase of 2,000 positions per fiscal year from FY2025-FY2031; during this period, each hospital may receive up to 75 additional positions in total under the bill and current law. Additionally, one-third of the positions that are made available under the bill must be allocated to hospitals that are already operating above applicable resident limits. The bill also requires the Government Accountability Office to report on strategies to increase the diversity of the health professional workforce, including with respect to representation from rural, low-income, and minority communities.

In committee Apr 7, 2023 1 co-sponsor
Co-sponsor HR 1825
In committee · United States House · Co-sponsor
Right to Try Clarification Act

Right to Try Clarification Act This bill specifies that investigational drugs that are provided via the Right to Try pathway are exempt from restrictions that would otherwise apply under the Controlled Substances Act (e.g., restrictions on the use or possession of schedule I controlled substances). The Right to Try pathway allows drug manufacturers to provide certain investigational drugs for which a Phase I clinical trial has been completed, but that have not yet received approval from the Food and Drug Administration, directly to individuals who have imminently life-threatening diseases or conditions and who have exhausted other treatment options and are unable to participate in clinical trials.

In committee Apr 7, 2023 1 co-sponsor
Co-sponsor HR 1839
In committee · United States House · Co-sponsor
Combating Illicit Xylazine Act

Maddy summaryHR 1839, the Combating Illicit Xylazine Act, makes the illicit use and distribution of xylazine a federal crime by adding it to the Controlled Substances Act. The bill broadly defines xylazine to cover numerous chemical variants and prohibits human use or non-licit distribution, while preserving legitimate veterinary and pharmaceutical uses. It requires tracking xylazine in drug supply chains and mandates two reports to Congress within 1 and 4 years on its prevalence, sources, and whether it should be rescheduled. The bill directly affects individuals distributing or using xylazine illicitly, including as an additive to drugs like fentanyl, and aims to address its public health risks. Congress declared illicit xylazine an "emerging drug threat" under existing law.

In committee Apr 7, 2023 1 co-sponsor
Showing 681 to 690 of 1,182 bills
Previous 1 … 68 69 70 … 119 Next